Results 161 to 170 of about 32,868,481 (282)

Misinterpreting the p value [PDF]

Anaesthesia, 2017
openaire   +2 more sources

Bibliometric analysis of the reporting of p values in the summaries of anaesthetic publications. [PDF]

Anaesthesia
Huber M, Fuchs A.
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Interpreting Trends in Self-Efficacy: Why P-Values Alone Do Not Tell the Full Story. [PDF]

Asian Pac J Cancer Prev
Jena PK, Mohapatra D.
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Three common misuses of P values

Dental Hypotheses, 2016
Jeehyoung Kim, Heejung Bang
doaj   +1 more source

Beyond P -values: the promise of Bayesian interpretation in surgical meta-analysis. [PDF]

Int J Surg
Tai KY, Lai PC, Huang YT.
europepmc   +1 more source

ASN guidelines on P values. [PDF]

Am J Clin Nutr, 2022
Verhoef H, Feskens E, van 't Veer P, Prentice AM.   +3 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Trends in the distribution of P values in epidemiology journals: a statistical, P-curve, and simulation study. [PDF]

Am J Epidemiol
Ackley SF, Andrews RM, Seaman C, Flanders M, Chen R, Wang J, Lopes G, Sims KD, Buto P, Ferguson E, Allen IE, Glymour MM.   +11 more
europepmc   +1 more source